Delivering Value To Those We Serve

Overview

Recent News

Date Title and Summary
Toggle Summary Assertio Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference
LAKE FOREST, Illinois , Aug. 20, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the 17 th Annual Morgan Stanley Global Healthcare Conference in a session scheduled for 11:45 a.m.
Toggle Summary Assertio Therapeutics Announces Exchange Offer of $200 Million of its Currently Outstanding 2.50% Convertible Notes Due 2021
LAKE FOREST, Ill. , Aug. 09, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) (“Assertio”) today announced it has entered into separate, privately negotiated exchange agreements (the “Exchange Agreements”) with a limited number of holders of Assertio’s currently outstanding 2.50%
Toggle Summary Assertio Therapeutics Announces Strong Second-Quarter 2019 Results
-- Reports Total Company GAAP Net Sales of $57.2 million , Total Company Non-GAAP Net Sales of $59.3 million , including Commercialization Agreement Revenues of $31.0 million -- -- Drives Continued Improvement in Operating Efficiencies as the Company  Executes on its Ongoing Transformation -- --

Upcoming Events

There are currently no events to display.

Recent SEC Filings

Filing date Description Form Filing Group View

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Amendment to a previously filed 4

4/A
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

IR Contact

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: 800.509.5586
http://www.continentalstock.com
 

Independent Registered Public Accounting Firm

Ernst & Young LLP
Palo Alto, CA
 

Investor Relations Contact

John B. Thomas
SVP, Investor Relations & Corporate Communications
jthomas@assertiotx.com